Clinical Trial Update: Weekly Topotecan Therapy in Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating weekly topotecan for ovarian cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED